Big Pharma got bigger yesterday with Merck's announcement that it will acquire rival Schering-Plough in a cash-and-stock transaction worth $41.1 billion. And it's being made easier courtesy of U.S ...

A judge dismissed Federal Trade Commission charges that Schering-Plough Corp. and Upsher-Smith Laboratories Inc. colluded to set prices for a blood pressure drug.

New Jersey drug makers Merck and Schering-Plough announced plans to combine in a $41.1 billion cash-and-stock deal that comes six weeks after rivals Pfizer and Wyeth unveiled their engagement.